Edu Butyrose
  • Responsabile scientifico
  • Articoli
    • BARRIERA EPITELIALE INTESTINALE
    • BUTIRRATO
    • COVID-19
    • GVHD – Graft-versus-Host Disease / Malattia del trapianto contro l’ospite
    • IBS
    • IBD
    • IDROSADENITE SUPPURATIVA
    • LINEE GUIDA
    • MALATTIE METABOLICHE
    • MALATTIA DIVERTICOLARE
    • RADIOTERAPIA
    • RIGENERAZIONE CUTANEA
  • Interviste
  • Eventi
  • Studi in corso
  • Riviste
  • Documenti utili
  • LSC
  • SILA
  • Logout
Seleziona una pagina
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota

Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota

da admin | Dic 23, 2025 | LETTERATURA BUTYROSE

Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, Andrea Buda, Brigida Barberio, Fabiana Zingone, Nicola Vitulo, Edoardo Vincenzo...
Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study

Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study

da admin | Nov 5, 2025 | LETTERATURA BUTYROSE

Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study Renato Cannizzaro, Stefania Maiero, Paola Pelizzo, Marco Gulotta, Sonia Facchin, Giulia Tessarolo, Antonella Zucchetto, Fabio Matrone, Stefano Realdon,...
Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study

Therapeutic Effects of Butyrate on Pediatric Obesity A Randomized Clinical Trial

da admin | Nov 5, 2025 | LETTERATURA BUTYROSE

Therapeutic Effects of Butyrate on Pediatric ObesityA Randomized Clinical Trial Serena Coppola, Rita Nocerino, Lorella Paparo, Giorgio Bedogni, Antonio Calignano, Carmen Di Scala, Anna Fiorenza de Giovanni di Santa Severina, Francesca De Filippis, Danilo Ercolini,...
Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

da admin | Nov 5, 2025 | LETTERATURA BUTYROSE

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease Sonia Facchin,  Nicola Vitulo, Matteo Calgaro, Andrea Buda, Chiara Romualdi, Daniel Pohl, Barbara Perini, Greta Lorenzon, Carla Marinelli, Renata D’Incà,...
Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study

Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease

da admin | Nov 5, 2025 | LETTERATURA BUTYROSE

Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease Antonio Tursi, Giorgia Procaccianti, Rudi De Bastiani, Silvia Turroni, Federica D’Amico,...
Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study

da admin | Nov 5, 2025 | LETTERATURA BUTYROSE

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study Federico De Blasio, Marta Vernero, Davide Giuseppe Ribaldone Visualizza...

Articoli recenti

  • Global guidelines on diverticular disease of the colon: the Fiesole Consensus report
  • Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain
  • Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
  • Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
  • Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners

Commenti recenti

    ideA-Z Project in progress S.r.l. | P.IVA: IT03373190960
    Corso Giacomo Matteotti, 48 – 20081 – Abbiategrasso (MI) | info@idea-z.it